Skip to main content
. 2014 Feb 13;6:ecurrents.hd.3304e87e460b4bb0dc519a29f4deccca. [Version 1] doi: 10.1371/currents.hd.3304e87e460b4bb0dc519a29f4deccca

Flow scheme of candidate proof-of-concept molecule evaluation as a potential therapeutic for HD in rodents.

Flow scheme of candidate proof-of-concept molecule evaluation as a potential therapeutic for HD in rodents.

This flow scheme is representative of the CHDI compound testing process.